Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives
Rainer Spanagel, Patrick Bach, Tobias Banaschewski, et al.
Addiction Biology (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 10
Methyl transfer in psilocybin biosynthesis
Jesse Hudspeth, Kai Rogge, Sebastian Dörner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats
Zitong Wang, Brett Robbins, R. L. Zhuang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111243-111243
Open Access
The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression
Tobias Buchborn, Hannes Kettner, Laura Kärtner, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder
Mary G. Hornick, Ashley Stefanski
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
The algorithmic agent perspective and computational neuropsychiatry: from etiology to advanced therapy in major depressive disorder
Giulio Ruffini, Francesca Castaldo, Edmundo Lopez-Sola, et al.
(2024)
Open Access | Times Cited: 2
Anxiety and personality
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 371-430
Closed Access | Times Cited: 2
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
Leah M. Salinsky, Christina R. Merritt, Joshua C. Zamora, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial
Laetitia Vanderijst, Felix Hever, Anne Buot, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
Anton Gomez-Escolar, Daniel Folch-Sanchez, Joanna Stefaniuk, et al.
CNS Drugs (2024) Vol. 38, Iss. 10, pp. 771-789
Closed Access | Times Cited: 1
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 1
Fundamentals of the septo-hippocampal system
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 241-284
Closed Access | Times Cited: 1
Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis
Kai Rogge, Tobias Wagner, Dirk Hoffmeister, et al.
FEBS Letters (2024)
Open Access | Times Cited: 1
Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice
Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, et al.
Neuroscience (2024) Vol. 559, pp. 156-165
Closed Access
The Algorithmic Agent Perspective and Computational Neuropsychiatry: From Etiology to Advanced Therapy in Major Depressive Disorder
Giulio Ruffini, Francesca Castaldo, Edmundo Lopez-Sola, et al.
Entropy (2024) Vol. 26, Iss. 11, pp. 953-953
Open Access
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial
Laetitia Vanderijst, Felix Hever, Anne Buot, et al.
Research Square (Research Square) (2024)
Open Access
What do hippocampal cell fields represent?
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 167-188
Closed Access
Overview
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 1-46
Closed Access
The neurology of anxiety—planning circuits
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 327-370
Closed Access
A theory of the septo-hippocampal system (SHS)
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 285-326
Closed Access
Symptoms and syndromes of anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 431-496
Closed Access
The neurology of anxiety—survival circuits
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 121-166
Closed Access
Ethology and anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 47-60
Closed Access
Memory and the septo-hippocampal system
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024), pp. 189-240
Closed Access
Page 1 - Next Page

Scroll to top